GlaxoSmithKline PLC (NYSE:GSK)

41.29
Delayed Data
As of Aug 11
 +0.35 / +0.85%
Today’s Change
31.43
Today|||52-Week Range
48.25
-12.13%
Year-to-Date

Stock Price Forecast

The 17 analysts offering 12-month price forecasts for GlaxoSmithKline PLC have a median target of 48.36, with a high estimate of 57.04 and a low estimate of 38.62. The median estimate represents a +17.13% increase from the last price of 41.29.

Analyst Recommendations

The current consensus among 20 polled investment analysts is to Hold stock in GlaxoSmithKline PLC. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.87
Sales
$11.9B
Reporting Date
Oct 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 74.67%
 
 
 
 
 
 
Growthannually -6.72%
 
 
 
 
 
 

Sales

Growthquarterly 19.96%
 
 
 
 
 
 
Growthannually 2.88%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.